CD8A and neoplasm: Moreover, we could reproduce findings that had previously been observed in homogenous tumor cohorts, such as increased numbers of TILs in malignancies that are characterized by high mutational burden, and observed specific transcriptional pathways in CD8+ T cells that were associated with clinical outcome27 in this cross-entity cohort.